• AIDS
  • As potent antiretroviral therapy for HIV has decreased AIDS-associated morbidity and mortality, chronic HCV has become a significant cause of morbidity and mortality in this population. (natap.org)
  • During HIV/AIDS micronutrients play a key role in the host defense systems-Micronutrients such as zinc and copper have been implicated to play important roles in immuno-physiologic functions. (asrjetsjournal.org)
  • While not classified as AIDS-defining, these malignancies are affecting the HIV/AIDS community greatly and have been referred to as "AIDS-associated malignancies" 1 , 5 or "opportunistic" cancers. (thebody.com)
  • This article will present an overview of AIDS-defining malignancies and other malignancies that are prevalent in the HIV-positive population. (thebody.com)
  • The risk of non-Hodgkin's lymphoma (NHL, also referred to as AIDS-related lymphoma) is substantially increased in the HIV-infected population, with risks ranging from approximately 40 to 400 times that of the general population, depending on the specific study and the type of NHL, though most studies report rates of 100 to 200 fold. (thebody.com)
  • disease
  • Despite the fact that the associations have been known almost as long as A1 and "A8" were known, the role of factors affecting disease are still not clear. (wikipedia.org)
  • HIV-1-infected women with SILs were not deeply immunosuppressed, with a mean CD4 count of 460/μl in women with low-grade SILs and 530/μl in women with high-grade SILs, suggesting that SILs occurred at an early stage of HIV disease. (aacrjournals.org)
  • Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. (clinicaltrials.gov)
  • End-stage liver disease has become a leading cause of death in HIV-infected persons. (natap.org)
  • Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. (clinicaltrials.gov)
  • I. Central nervous system (CNS) objective response rate at 12 weeks: defined as either a complete response or partial response provided there is no progression of extra-CNS disease, increasing steroid requirements, or worsening of neurologic signs and symptoms (NSS)^34 Lesions will be measured using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. (clinicaltrials.gov)
  • Treatment repeats every 21 days for 17 courses in the absence of disease progression or unacceptable toxicity. (clinicaltrials.gov)
  • study
  • However, as study sizes increased and D serotypes were described in more detail, the association of these loci moved from the MHC class I loci to the MHC class II loci. (wikipedia.org)
  • This locus in part of the HLA A1-B8-DR3-DQ2 haplotype (markers are A1, CW7, B8, BfS, C4AQ0, C4B1, DR3, DQ2) therefore one study concluded that C4AQ0 could explain the increased infectivity to HIV. (wikipedia.org)
  • We would like to summarize and share our experience in this field from a study conducted in African women with a high HIV prevalence, too recent to be included in the meta-analysis. (aacrjournals.org)
  • This is the first population-based study with adequate sample size that tests if SCD could protect from HIV. (pubmedcentralcanada.ca)
  • Descriptive cross-sectional study was conducted in the voluntary counselling and testing centre (VCT) at Comprehensive Care Clinics in Taita-Taveta County health care services, Coast, Kenya, blood samples obtained from 192 HIV sero-positive individuals, 18 years of age and gender matched healthy controls were analyzed for zinc and copper using atomic absorption spectrophotometer machine. (asrjetsjournal.org)
  • human
  • 3 , 5 , 6 , 9 In the presence of HIV, KS is associated with human herpesvirus 8 (HHV-8, also referred to KSHV for KS-associated herpesvirus). (thebody.com)
  • women
  • Furthermore, development of high-grade SILs was observed in 7 of the 38 HIV-positive women, but in none of the 56 HIV-negative women ( P = 0.001). (aacrjournals.org)
  • The HIV prevalence for Africane-American men was six times the rate for white men and the rate for Africane-American women was 18 times the rate for white women. (pubmedcentralcanada.ca)
  • early
  • In conclusion, waist-hip ratio has been identified as a more sensitive predictor and nutrition status maker than body mass index in early HIV hence can be a decisive benchmark for monitoring HIV progression. (asrjetsjournal.org)
  • However
  • Therapy for HIV in the context of HCV coinfection, however, can be problematic. (natap.org)